Tanaka Growth Fund (TGFRX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
47.63
+0.64 (1.36%)
May 28, 2025, 8:07 AM EDT
3.79% (1Y)
| Fund Assets | 20.09M |
| Expense Ratio | 1.99% |
| Min. Investment | $2,000 |
| Turnover | n/a |
| Dividend (ttm) | 3.16 |
| Dividend Yield | 6.72% |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 27, 2024 |
| Previous Close | 46.99 |
| YTD Return | 3.93% |
| 1-Year Return | 3.79% |
| 5-Year Return | 165.19% |
| 52-Week Low | 39.85 |
| 52-Week High | 857.00 |
| Beta (5Y) | 1.26 |
| Holdings | 24 |
| Inception Date | Dec 29, 1998 |
About TGFRX
The investment seeks growth of capital. The fund invests primarily in common stocks and other equity securities of small, medium and large capitalization companies. It invests up to 45% of its net assets, measured at the time of investment, in foreign securities, including multinational and emerging market securities. The fund is non-diversified.
Category Large Growth
Performance Rating Below Average
Risk Rating High
Stock Exchange NASDAQ
Ticker Symbol TGFRX
Share Class Class R
Index Index is not available on Lipper Database
Performance
TGFRX had a total return of 3.79% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.36%.
Top 10 Holdings
76.59% of assets| Name | Symbol | Weight |
|---|---|---|
| Corcept Therapeutics Incorporated | CORT | 14.86% |
| Apple Inc. | AAPL | 13.33% |
| NVIDIA Corporation | NVDA | 9.50% |
| Catalyst Pharmaceuticals, Inc. | CPRX | 8.72% |
| NexGen Energy Ltd. | n/a | 6.69% |
| Aflac Incorporated | AFL | 5.39% |
| Stifel Financial Corp. | SF | 5.36% |
| The Carlyle Group, Inc. | n/a | 4.83% |
| Symbotic, Inc. Class A | n/a | 4.32% |
| Onto Innovation Inc. | ONTO | 3.59% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 27, 2024 | $3.15651 | Dec 27, 2024 |
| Dec 27, 2022 | $0.03145 | Dec 27, 2022 |